Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析

◆英語タイトル:Cocrystal Pharma Inc (COCP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15011
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline products include Nucleoside NS5B, NS5A, NNI NS5B, and NS3 Helicase. Cocrystal Pharma offers products such as non nucleoside inhibitors, novel pan-genotypic nucleoside prodrugs, and helicase inhibitors. The company’s novel pan-genotypic nucleoside pro-drugs are used in non-toxic, resisting drug-drug interactions, barrier to drug resistance, short duration treatment and others. Its novel antiviral therapeutics is used in treatments for serious and chronic viral diseases. The company operates in Tucker and Bothell. Cocrystal Pharma is headquartered in Tucker, Georgia, the US.

Cocrystal Pharma Inc Key Recent Developments

Jan 07,2019: Cocrystal Announces Board Changes
Nov 30,2018: Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference November 30, 2018
Nov 12,2018: Cocrystal Pharma reports 2018 third quarter financial results and provides corporate update
Oct 08,2018: Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus

This comprehensive SWOT profile of Cocrystal Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cocrystal Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cocrystal Pharma Inc – Key Information
Cocrystal Pharma Inc – Overview
Cocrystal Pharma Inc – Key Employees
Cocrystal Pharma Inc – Key Employee Biographies
Cocrystal Pharma Inc – Key Operational Heads
Cocrystal Pharma Inc – Major Products and Services
Cocrystal Pharma Inc – History
Cocrystal Pharma Inc – Company Statement
Cocrystal Pharma Inc – Locations And Subsidiaries
Cocrystal Pharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cocrystal Pharma Inc – Business Description
Cocrystal Pharma Inc – Corporate Strategy
Cocrystal Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Cocrystal Pharma Inc – Strengths
Cocrystal Pharma Inc – Weaknesses
Cocrystal Pharma Inc – Opportunities
Cocrystal Pharma Inc – Threats
Cocrystal Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cocrystal Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cocrystal Pharma Inc, Key Information
Cocrystal Pharma Inc, Key Ratios
Cocrystal Pharma Inc, Share Data
Cocrystal Pharma Inc, Major Products and Services
Cocrystal Pharma Inc, History
Cocrystal Pharma Inc, Key Employees
Cocrystal Pharma Inc, Key Employee Biographies
Cocrystal Pharma Inc, Key Operational Heads
Cocrystal Pharma Inc, Other Locations
Cocrystal Pharma Inc, Subsidiaries
Cocrystal Pharma Inc, Key Manufacturing facilities
Cocrystal Pharma Inc, Key Competitors
Cocrystal Pharma Inc, SWOT Analysis
Cocrystal Pharma Inc, Ratios based on current share price
Cocrystal Pharma Inc, Annual Ratios
Cocrystal Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cocrystal Pharma Inc, Performance Chart
Cocrystal Pharma Inc, Ratio Charts

★海外企業調査レポート[Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Columbus Life Insurance Company:企業の戦略的SWOT分析
    Columbus Life Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Aerojet Rocketdyne Holdings Inc:企業の戦略・SWOT・財務情報
    Aerojet Rocketdyne Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Aerojet Rocketdyne Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ackermans & Van Haaren NV:戦略・SWOT・企業財務分析
    Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report Summary Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sinohydro Corporation Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Sinohydro Corporation Co., Ltd (Sinohydro), a subsidiary of China Hydropower Construction Group International Engineering Co., Ltd., is an engineering and construction company. Its portfolio of services includes general construction, engineering, procurement and construction (EPC), and inves …
  • Xcel Energy Inc (XEL)-エネルギー分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Westwater Resources, Inc.:企業のM&A・事業提携・投資動向
    Westwater Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westwater Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Recordati S.p.A.:企業の戦略・SWOT・財務分析
    Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Medical Transcription Billing Corp (MTBC)-医療機器分野:企業M&A・提携分析
    Summary Medical Transcription Billing Corp (Medical Transcription) is a healthcare IT company that offers web-based solutions and related business services. The company offers electronic health records, practice management software, and patient engagement software. Its products comprise ChartsPro, P …
  • National University of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary National University of Singapore (NUS) is an educational university that offers research and training services. The university provides undergraduate, graduate and double degree programmes. It offers programs in the areas of arts and social sciences, business, computing, dentistry, design an …
  • Sushico:企業の戦略・SWOT・財務分析
    Sushico - Strategy, SWOT and Corporate Finance Report Summary Sushico - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Knopp Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that develops and markets medicines for the treatment of neurological disorders. The company's lead product candidate, dexpramipexole, is an orally bioavailable small molecule which is used for the treatmen …
  • KapStone Paper and Packaging Corporation:戦略・SWOT・企業財務分析
    KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Atmos Energy Corp (ATO):石油・ガス:M&Aディール及び事業提携情報
    Summary Atmos Energy Corp (Atmos Energy) is a fully-regulated natural gas distributor. Together with its subsidiaries, the company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public authority and industrial customers.The company is also in …
  • Ramot:製薬・医療:M&Aディール及び事業提携情報
    Summary Ramot is a business engagement center of Tel Aviv University that offers technology transfer services. The center manages new technologies from university laboratories to the domestic and commercial markets. It also offers services which include research and development programs, securing ap …
  • Ernst & Young Global Ltd:戦略・SWOT・企業財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Heat Biologics Inc (HTBX):企業の財務・戦略的SWOT分析
    Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆